RetractedArticlePloS one2012

Concomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer.

Sophie Deharvengt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.